<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Zhou JN</submitter><funding>Guangzhou Health Care and Cooperative Innovation Major Project</funding><funding>National Natural Science Foundation of China</funding><funding>National Science and Technology Major Projects for "Major New Drugs Innovation and Development"</funding><funding>National Key Research and Development Program of China</funding><pagination>e2201166</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9353477</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>9(22)</volume><pubmed_abstract>Cancer stem cells (CSCs) are reported to play essential roles in chemoresistance and metastasis. Pathways regulating CSC self-renewal and proliferation, such as Hedgehog, Notch, Wnt/β-catenin, TGF-β, and Myc, may be potential therapeutic targets. Here, a functional screening from the focused library with 365 compounds is performed by a step-by-step strategy. Among these candidate molecules, phenyl-2-pyrimidinyl ketone 4-allyl-3-amino selenourea (CU27) is chosen for further identification because it proves to be the most effective compound over others on CSC inhibition. Through ingenuity pathway analysis, it is shown CU27 may inhibit CSC through a well-known stemness-related transcription factor c-Myc. Gene set enrichment analysis, dual-luciferase reporter assays, expression levels of typic</pubmed_abstract><journal>Advanced science (Weinheim, Baden-Wurttemberg, Germany)</journal><pubmed_title>A Functional Screening Identifies a New Organic Selenium Compound Targeting Cancer Stem Cells: Role of c-Myc Transcription Activity Inhibition in Liver Cancer.</pubmed_title><pmcid>PMC9353477</pmcid><funding_grant_id>2017YFA0103104</funding_grant_id><funding_grant_id>2017YFA0103103</funding_grant_id><funding_grant_id>81773137</funding_grant_id><funding_grant_id>2017YFA0103100</funding_grant_id><funding_grant_id>2018ZX09711003</funding_grant_id><funding_grant_id>201704020224</funding_grant_id><pubmed_authors>Xu YC</pubmed_authors><pubmed_authors>Zhang MM</pubmed_authors><pubmed_authors>Zeng Q</pubmed_authors><pubmed_authors>Xi JF</pubmed_authors><pubmed_authors>He LJ</pubmed_authors><pubmed_authors>Zhong W</pubmed_authors><pubmed_authors>Zhou JN</pubmed_authors><pubmed_authors>Zhang M</pubmed_authors><pubmed_authors>Jia YL</pubmed_authors><pubmed_authors>Nan X</pubmed_authors><pubmed_authors>Pei XT</pubmed_authors><pubmed_authors>Zhou XB</pubmed_authors><pubmed_authors>Wang HY</pubmed_authors><pubmed_authors>Fan SY</pubmed_authors><pubmed_authors>Wang DX</pubmed_authors><pubmed_authors>Wang XK</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Yue W</pubmed_authors><pubmed_authors>Zhang B</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Functional Screening Identifies a New Organic Selenium Compound Targeting Cancer Stem Cells: Role of c-Myc Transcription Activity Inhibition in Liver Cancer.</name><description>Cancer stem cells (CSCs) are reported to play essential roles in chemoresistance and metastasis. Pathways regulating CSC self-renewal and proliferation, such as Hedgehog, Notch, Wnt/β-catenin, TGF-β, and Myc, may be potential therapeutic targets. Here, a functional screening from the focused library with 365 compounds is performed by a step-by-step strategy. Among these candidate molecules, phenyl-2-pyrimidinyl ketone 4-allyl-3-amino selenourea (CU27) is chosen for further identification because it proves to be the most effective compound over others on CSC inhibition. Through ingenuity pathway analysis, it is shown CU27 may inhibit CSC through a well-known stemness-related transcription factor c-Myc. Gene set enrichment analysis, dual-luciferase reporter assays, expression levels of typic</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2026-05-10T06:25:06.261Z</modification><creation>2024-11-09T19:32:18.539Z</creation></dates><accession>S-EPMC9353477</accession><cross_references><pubmed>35652264</pubmed><doi>10.1002/advs.202201166</doi></cross_references></HashMap>